18,19-dihydroetorphine has been researched along with Substance-Related Disorders in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (70.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Husbands, SM; Lewis, JW | 1 |
Feng, JL; Hu, XY; Liu, F; Luo, Y | 1 |
Cai, ZJ; Ge, Y; Li, M; Sun, WL | 1 |
Kaneto, H; Takahashi, M; Tokuyama, S | 1 |
Harris, LS; Kim, SA; Martin, TJ; Smith, JE | 1 |
Beardsley, PM; Harris, LS | 1 |
Aceto, MD; Bowman, ER; Harris, LS | 1 |
Li, FY; Li, Y; Wu, WR; Zheng, JW | 1 |
Aceto, MD; Harris, LS; Ji, Z; Scates, SM | 1 |
Fang, L; Kawase, M; Morimoto, Y; Ohmori, S; Saito, S | 1 |
1 review(s) available for 18,19-dihydroetorphine and Substance-Related Disorders
Article | Year |
---|---|
Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Drug Evaluation, Preclinical; Etorphine; Humans; Hydromorphone; Ligands; Morphinans; Narcotic Antagonists; Receptors, Opioid, mu; Structure-Activity Relationship; Substance-Related Disorders | 2003 |
9 other study(ies) available for 18,19-dihydroetorphine and Substance-Related Disorders
Article | Year |
---|---|
Identification of dihydroetorphine in biological fluids by gas chromatography-mass spectrometry.
Topics: Etorphine; Gas Chromatography-Mass Spectrometry; Humans; Imidazoles; Methylene Chloride; Sensitivity and Specificity; Substance-Related Disorders | 1995 |
[Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
Topics: Administration, Sublingual; Adolescent; Adult; Analgesics, Opioid; Etorphine; Female; Heroin; Heroin Dependence; Humans; Male; Methadone; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice.
Topics: Analgesics; Animals; Body Weight; Drug Tolerance; Etorphine; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Substance-Related Disorders | 1993 |
Potent reinforcing effects of dihydroetorphine in rats.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Etorphine; Fentanyl; Heroin; Male; Morphine; Morphine Derivatives; Rats; Rats, Inbred F344; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Evaluation of the discriminative stimulus and reinforcing effects of dihydroetorphine.
Topics: Analgesics, Opioid; Animals; Discrimination Learning; Dose-Response Relationship, Drug; Etorphine; Heroin; Macaca mulatta; Male; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Substance-Related Disorders | 1997 |
Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity.
Topics: Analgesics, Opioid; Animals; Etorphine; Female; Macaca mulatta; Male; Mice; Mice, Inbred ICR; Pain Threshold; Receptors, Opioid, mu; Substance-Related Disorders | 1997 |
Immunosuppressive effects of intravenous self administration of dihydroetorphine on lymphocyte functions in rats.
Topics: Animals; Cell Division; Etorphine; Immunosuppressive Agents; Injections, Intravenous; Interleukin-2; Lymphocytes; Male; Rats; Rats, Wistar; Self Administration; Spleen; Substance-Related Disorders | 1998 |
Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Etorphine; Infusions, Parenteral; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2000 |
Tolerance to analgesia and dependence liability by topical application of dihydroetorphine to hairless rats.
Topics: Administration, Cutaneous; Analgesics, Opioid; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Tolerance; Etorphine; Formaldehyde; Inflammation; Infusions, Intravenous; Injections, Subcutaneous; Male; Morphine; Naloxone; Narcotic Antagonists; Rats; Rats, Nude; Substance-Related Disorders; Time Factors; Weight Loss | 2001 |